Antibodies targeting the normal PrP version of the prion protein have been found in humans selected at random with no history of any associated transmissible spongiform encephalopathies. The significance is that prion proteins ...
Aug 17, 2020
0
5
B cells are white blood cells that develop to produce antibodies. These antibodies, or immunoglobulins, can bind to harmful foreign particles (such as viruses or disease-causing bacteria) to stop them invading and infecting ...
Aug 5, 2020
0
453
An exploratory analysis of data from the CANTOS (Canakinumab Anti-inflammatory Thrombosis Outcomes Study) randomized double-blind, placebo-controlled trial found that patients receiving interleukin-1β (IL-1β) inhibitors ...
Aug 4, 2020
0
5
The extraordinary progress that has been achieved in the biomedical sciences in the modern era can be attributed in large measure to imaging technologies that have allowed scientists to observe the structure and function ...
Jul 23, 2020
0
180
Some supposedly inert ingredients in common drugs—such as dyes and preservatives—may potentially be biologically active and could lead to unanticipated side effects, according to a preliminary new study by researchers ...
Jul 23, 2020
1
95
Elderly people are more prone to infectious diseases as the function of their immune system continuously declines with progression of age. This becomes especially apparent during seasonal influenza outbreaks or the occurrence ...
Jul 6, 2020
0
639
In an article published today in Science, a multidisciplinary research team from morethan 10 universities and research institutes outlines how integrating a more diverseset of species and environments could enhance the biomedical ...
Jul 2, 2020
0
123
Scientists fear a new Ebola strain might emerge in the Democratic Republic of Congo if two versions of the disease mix together to form a new, potentially deadlier version.
Jun 26, 2020
0
2
A multi-institutional group of researchers led by Harvard Medical School and the Novartis Institutes for BioMedical Research has created an open-source machine learning tool that identifies proteins associated with drug side ...
Jun 18, 2020
0
43
A team of UMass Medical School researchers has identified a promising new therapeutic target in hepatoblastoma, a rare, primarily pediatric liver cancer for which successful treatment strategies have been elusive.
Jun 4, 2020
0
0
